Average Co-Inventor Count = 6.16
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Smithkline Beecham Corporation (5 from 2,198 patents)
2. Glaxo Group Limited (4 from 1,168 patents)
3. Glaxosmithkline LLC (2 from 356 patents)
4. Glaxo Wellcome Inc. (1 from 281 patents)
5. Glaxosmithkline Intellectual Property Development Limited (1 from 230 patents)
13 patents:
1. 10004724 - Compounds alpha v beta 6 integrin antagonists
2. 7750026 - Fused heteroaryl derivatives and their use as p38 kinase inhibitors
3. 7687532 - Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of I.A. rheumatoid arthritis
4. 7642276 - Fused heteroaryl derivatives for use as P38 kinase inhibitors
5. 7622464 - Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases
6. 7572790 - Biphenyl carboxylic amide p38 kinase inhibitors
7. 7425555 - Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
8. 7157457 - Compounds useful in the treatment of inflammatory diseases
9. 7101882 - Morpholin-acetamide derivatives for the treatment of inflammatory diseases
10. 6610665 - 2-(purin-9-yl)-tetrahydrofuran-3, 4-diol derivatives
11. 6534486 - 2-(purin-9-yl)-Tetrahydrofuran-3,4-diol derivatives
12. 5998388 - Adenosine derivatives
13. 5066678 - Phenethandamine derivatives and pharmaceutical use thereof